Roy Elias, MD, UT Southwestern Medical Center (IMAGE)
Caption
An autoimmune side effect of immune checkpoint inhibitor (ICI) drugs could signal improved control of kidney cancer, according to a new study by researchers in UT Southwestern's Kidney Cancer Program (KCP).
Credit
UT Southwestern Medical Center
Usage Restrictions
None
License
Licensed content